fluorobenzenes has been researched along with Atheroma in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 30 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daida, H; Hata, M; Kaku, K; Kawamori, R; Kishimoto, J; Kurabayashi, M; Masuda, I; Nohara, R; Sakuma, I; Yamazaki, T; Yokoi, H; Yoshida, M | 1 |
| Hagita, S; Osaka, M; Yoshida, M | 1 |
| Ballantyne, CM; Barter, PJ; Chapman, MJ; Erbel, R; Kataoka, Y; Libby, P; Nicholls, SJ; Nissen, SE; Puri, R; Raichlen, JS; St John, J; Uno, K; Wolski, K | 1 |
| Ballantyne, CM; Barter, PJ; Chapman, MJ; Erbel, R; Kataoka, Y; Libby, P; Nicholls, SJ; Nissen, SE; Puri, R; Raichlen, JS; Shao, M; Uno, K | 1 |
| de Graaf, MA; Jukema, JW | 1 |
| Daida, H; Daimon, M; Hattori, N; Kuroki, T; Miyamoto, N; Miyauchi, K; Shimada, Y; Tanaka, R; Tanaka, Y; Ueno, Y; Urabe, T; Watanabe, M; Yamashiro, K | 1 |
| Boudoulas, H; Chalikias, G; Kapelouzou, A; Karayannakos, P; Konstantinides, S; Kostakis, A; Schäfer, K; Tentes, I; Tziakas, D | 1 |
| Ayaori, M; Iguchi, Y; Ikewaki, K; Kihara, T; Komatsu, T; Mochio, S; Momiyama, Y; Nagata, M; Nakaya, K; Sasaki, M; Sato, H; Takiguchi, S; Uto-Kondo, H; Yakushiji, E; Yogo, M | 1 |
| Mintz, GS | 1 |
| Ballantyne, CM; Barter, PJ; Chapman, MJ; Erbel, R; Kataoka, Y; Libby, P; Nicholls, SJ; Nissen, SE; Puri, R; Raichlen, JS; Tuzcu, EM; Uno, K; Wolski, K | 1 |
| Akasaka, M; Kaneko, K; Kiribayashi, N; Kubota, I; Niizeki, T; Omi, K; Saito, H; Sasaki, T; Sugawara, S; Takahashi, T | 1 |
| Chi, J; Guo, H; Ji, Z; Jiang, C; Lv, H; Tang, W; Zhai, X; Zhao, F | 1 |
| Cai, J; Du, R; Gao, P; Leng, WX; Liu, DQ; Ma, L; Wang, QJ; Wu, HM; Ye, P; Zhao, XQ | 1 |
| Ballantyne, CM; Barter, PJ; Chapman, MJ; Cho, L; Erbel, R; Kataoka, Y; Libby, P; Nicholls, SJ; Nissen, SE; Puri, R; Raichlen, JS; Shao, M; Stegman, B; Uno, K | 1 |
| Biacchi, D; Bononi, M; Borrelli, V; Di Marzo, L; Sapienza, P; Sterpetti, AV; Tartaglia, E; Venturini, L | 1 |
| Chen, M; Huang, BT | 1 |
| Nicholls, SJ; Puri, R; Shao, M; Stegman, B | 1 |
| Cipollone, F; Fischer, JW; Marzoll, A; Melchior-Becker, A | 1 |
| Ahmed, K; Ahn, Y; Cho, JG; Cho, SH; Choi, YH; Hachinohe, D; Hong, YJ; Hwang, SH; Jeong, MH; Kang, JC; Kim, JH; Kim, KH; Ko, JS; Lee, MG; Park, HW; Park, JC; Park, KH; Sim, DS; Yoon, HJ; Yoon, NS | 1 |
| Aizawa, K; Ikeda, U; Izawa, A; Kasai, H; Koshikawa, M; Koyama, J; Kumazaki, S; Miyashita, Y; Otagiri, K; Tomita, T; Tsutsui, H | 1 |
| Ahn, TH; Choi, IS; Chung, WJ; Han, SH; Kang, WC; Lee, K; Park, YM; Shin, EK; Shin, MS | 1 |
| Horii, M; Ishigami, K; Kawakami, R; Kawata, H; Matsumoto, T; Nakagawa, H; Nishida, T; Okayama, S; Saito, Y; Senoo, A; Soeda, T; Somekawa, S; Sugawara, Y; Sung, JH; Takeda, Y; Uemura, S | 1 |
| Boersma, E; Garcia-Garcia, HM; Magro, M; Serruys, PW; Simsek, C; van Geuns, RJ | 1 |
| Fu, X; Lu, MM; Luo, RN; Tao, LJ; Wang, R; Zhou, J | 1 |
| Garcia-Garcia, HM; Okamura, T; Serruys, PW; Shin, ES | 1 |
| Ahn, JM; Kang, SJ; Kim, WJ; Kim, YH; Lee, CW; Lee, JY; Lee, SW; Park, DW; Park, SJ; Park, SW; Song, HG | 1 |
| Spiegel, R | 1 |
| Boersma, E; de Boer, S; Duckers, HJ; Garcia-Garcia, HM; Girasis, C; Lenzen, M; Magro, M; Raichlen, J; Regar, E; Serruys, PW; Simsek, C; van der Giessen, W; van der Steen, T; van Geuns, RJ; van Mieghem, N; Zijlstra, F | 1 |
| Daida, H; Hirayama, A; Hiro, T; Matsuzaki, M; Saito, S; Takayama, T; Yamagishi, M; Yamaguchi, T | 1 |
| Egede, R; Hansen, HS; Hansen, KN; Jensen, LO; Junker, A; Thayssen, P | 1 |
14 trial(s) available for fluorobenzenes and Atheroma
| Article | Year |
|---|---|
Effect of long-term intensive lipid-lowering therapy with rosuvastatin on progression of carotid intima-media thickness--Justification for Atherosclerosis Regression Treatment (JART) extension study.
Topics: Aged; Atherosclerosis; Carotid Intima-Media Thickness; Female; Fluorobenzenes; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Plaque, Atherosclerotic; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Time Factors | 2013 |
Factors underlying regression of coronary atheroma with potent statin therapy.
Topics: Analysis of Variance; Atorvastatin; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Endosonography; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Plaque, Atherosclerotic; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Sulfonamides | 2013 |
Coronary atheroma volume and cardiovascular events during maximally intensive statin therapy.
Topics: Angina, Unstable; Atorvastatin; Cholesterol, LDL; Coronary Artery Disease; Female; Fluorobenzenes; Heptanoic Acids; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Plaque, Atherosclerotic; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Stroke; Sulfonamides; Treatment Outcome; Ultrasonography, Interventional | 2013 |
Rationale and design of the EPISTEME trial: efficacy of post-stroke intensive rosuvastatin treatment for aortogenic embolic stroke.
Topics: Aorta; Brain Ischemia; Echocardiography, Transesophageal; Embolism; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Plaque, Atherosclerotic; Prospective Studies; Pyrimidines; Research Design; Rosuvastatin Calcium; Stroke; Sulfonamides | 2014 |
Intensive lipid lowering therapy with titrated rosuvastatin yields greater atherosclerotic aortic plaque regression: Serial magnetic resonance imaging observations from RAPID study.
Topics: Aged; Anthropometry; Aorta; Atherosclerosis; C-Reactive Protein; Cholesterol, LDL; Endothelium, Vascular; Female; Fluorobenzenes; Guidelines as Topic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Magnetic Resonance Imaging; Male; Middle Aged; Plaque, Atherosclerotic; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome | 2014 |
Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURN.
Topics: Aged; Atorvastatin; Biomarkers; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Female; Fluorobenzenes; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Plaque, Atherosclerotic; Pyrimidines; Pyrroles; Research Design; Risk Factors; Rosuvastatin Calcium; Sulfonamides; Time Factors; Treatment Outcome; Tunica Intima; Ultrasonography, Interventional | 2014 |
Early decrease in carotid plaque lipid content as assessed by magnetic resonance imaging during treatment of rosuvastatin.
Topics: Aged; Asymptomatic Diseases; Biomarkers; Carotid Artery Diseases; Carotid Artery, Common; China; Cholesterol, LDL; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Magnetic Resonance Imaging; Male; Middle Aged; Necrosis; Plaque, Atherosclerotic; Predictive Value of Tests; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Time Factors; Treatment Outcome | 2014 |
High-intensity statin therapy alters the natural history of diabetic coronary atherosclerosis: insights from SATURN.
Topics: Aged; Atorvastatin; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Diabetes Mellitus; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Plaque, Atherosclerotic; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Sulfonamides; Ultrasonography, Interventional | 2014 |
Comparison of effects of rosuvastatin and atorvastatin on plaque regression in Korean patients with untreated intermediate coronary stenosis.
Topics: Atorvastatin; C-Reactive Protein; Cholesterol, LDL; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Disease Progression; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Korea; Male; Plaque, Atherosclerotic; Prospective Studies; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome; Ultrasonography, Interventional | 2011 |
Rosuvastatin combined with ramipril significantly reduced atheroma volume by anti-inflammatory mechanism: comparative analysis with rosuvastatin alone by intravascular ultrasound.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Drug Therapy, Combination; Female; Fluorobenzenes; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Plaque, Atherosclerotic; Prospective Studies; Pyrimidines; Ramipril; Rosuvastatin Calcium; Sulfonamides; Ultrasonography, Interventional | 2012 |
Intensive lipid-lowering therapy with rosuvastatin stabilizes lipid-rich coronary plaques. -Evaluation using dual-source computed tomography.-.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Coronary Angiography; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Metabolism; Male; Middle Aged; Plaque, Atherosclerotic; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Tomography, X-Ray Computed | 2011 |
Comparison of effects of atorvastatin (20 mg) versus rosuvastatin (10 mg) therapy on mild coronary atherosclerotic plaques (from the ARTMAP trial).
Topics: Atorvastatin; Coronary Angiography; Coronary Artery Disease; Female; Fluorobenzenes; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Male; Middle Aged; Plaque, Atherosclerotic; Prospective Studies; Pyrimidines; Pyrroles; Republic of Korea; Rosuvastatin Calcium; Sulfonamides; Ultrasonography, Interventional | 2012 |
High HbA1c levels correlate with reduced plaque regression during statin treatment in patients with stable coronary artery disease: results of the coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese
Topics: Aged; Asian People; Biomarkers; Chi-Square Distribution; Coronary Artery Disease; Coronary Vessels; Female; Fluorobenzenes; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Japan; Linear Models; Lipids; Male; Middle Aged; Multivariate Analysis; Plaque, Atherosclerotic; Pyrimidines; Risk Assessment; Risk Factors; Rosuvastatin Calcium; Sulfonamides; Time Factors; Treatment Outcome; Ultrasonography, Interventional | 2012 |
Influence of high-dose lipid lowering treatment compared to low-dose lipid lowering treatment on plaque composition assessed by intravascular ultrasound virtual histology in patients with ST-segment elevation acute myocardial infarction: the VIRHISTAMI tr
Topics: Aged; Cholesterol, LDL; Electrocardiography; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Necrosis; Plaque, Atherosclerotic; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Ultrasonography, Interventional | 2013 |
16 other study(ies) available for fluorobenzenes and Atheroma
| Article | Year |
|---|---|
In vivo imaging of leukocyte recruitment to the atheroprone femoral artery reveals anti-inflammatory effects of rosuvastatin.
Topics: Animals; Anti-Inflammatory Agents; Aorta; Apolipoproteins E; Cell Adhesion; Diagnostic Imaging; Femoral Artery; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leukocytes; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Microscopy, Fluorescence; NADPH Oxidases; Oxidative Stress; Plaque, Atherosclerotic; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Vascular Cell Adhesion Molecule-1 | 2013 |
High coronary plaque load: a heavy burden.
Topics: Atorvastatin; Coronary Artery Disease; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Plaque, Atherosclerotic; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Sulfonamides | 2013 |
Erythrocyte membrane cholesterol and lipid core growth in a rabbit model of atherosclerosis: modulatory effects of rosuvastatin.
Topics: Animals; Atherosclerosis; Cholesterol; Diet, Atherogenic; Disease Models, Animal; Erythrocyte Membrane; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Plaque, Atherosclerotic; Pyrimidines; Rabbits; Rosuvastatin Calcium; Sulfonamides | 2013 |
Beyond greyscale IVUS assessment of progression/regression: it should be simple, but it's not.
Topics: Atorvastatin; Coronary Artery Disease; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Plaque, Atherosclerotic; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Sulfonamides; Ultrasonography, Interventional | 2014 |
Rosuvastatin improves plaque morphology in cerebral embolism patients with normal low-density lipoprotein and severe aortic arch plaque.
Topics: Aged; Aorta, Thoracic; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracranial Embolism; Lipids; Lipoproteins, LDL; Male; Middle Aged; Plaque, Atherosclerotic; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome | 2014 |
Yellow wine polyphenolic compounds inhibit matrix metalloproteinase-2, -9 expression and improve atherosclerotic plaque in LDL-receptor-knockout mice.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice, Inbred C57BL; Mice, Knockout; Oryza; Plaque, Atherosclerotic; Polyphenols; Pyrimidines; Receptors, LDL; Rosuvastatin Calcium; Sulfonamides; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Wine | 2014 |
Statins reduce levels of metalloproteinases in patients with carotid occlusive disease.
Topics: Aged; Angiography; Asymptomatic Diseases; Carotid Stenosis; Disease Progression; Drug Monitoring; Fluorobenzenes; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Metalloproteases; Middle Aged; Plaque, Atherosclerotic; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Tissue Inhibitor of Metalloproteinases; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography, Doppler, Color | 2014 |
Comment on Stegman et al. High-intensity statin therapy alters the natural history of diabetic coronary atherosclerosis: insights from SATURN. Diabetes Care 2014;37:3114-3120.
Topics: Atorvastatin; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Plaque, Atherosclerotic; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Sulfonamides | 2015 |
Response to Comment on Stegman et al. High-intensity statin therapy alters the natural history of diabetic coronary atherosclerosis: insights from SATURN. Diabetes Care 2014;37:3114-3120.
Topics: Atorvastatin; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Plaque, Atherosclerotic; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Sulfonamides | 2015 |
Small leucine-rich proteoglycans in atherosclerotic lesions: novel targets of chronic statin treatment?
Topics: Animals; Apolipoproteins E; Atherosclerosis; Biglycan; Cell Line; Collagen; Decorin; Endarterectomy, Carotid; Extracellular Matrix Proteins; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leucine; Lipoproteins, LDL; Male; Mice; Mice, Knockout; Plaque, Atherosclerotic; Proteoglycans; Pyrimidines; Rosuvastatin Calcium; Sulfonamides | 2011 |
Early intervention with rosuvastatin decreases the lipid components of the plaque in acute coronary syndrome: analysis using integrated backscatter IVUS (ELAN study).
Topics: Acute Coronary Syndrome; Aged; Cholesterol, LDL; Coronary Artery Disease; Female; Fluorobenzenes; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Metabolism; Male; Middle Aged; Plaque, Atherosclerotic; Pyrimidines; Retrospective Studies; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome; Ultrasonography, Interventional | 2011 |
Change in near-infrared spectroscopy of a coronary artery after 1-year treatment with high dose rosuvastatin.
Topics: Adult; Coronary Artery Disease; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Plaque, Atherosclerotic; Pyrimidines; Rosuvastatin Calcium; Spectroscopy, Near-Infrared; Sulfonamides; Treatment Outcome | 2012 |
[Impact of rosuvastatin on atherosclerosis lesions in apolipoprotein E knockout mice].
Topics: Animals; Antigens, Differentiation; Apolipoproteins E; Atherosclerosis; Diet, High-Fat; Fluorobenzenes; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Plaque, Atherosclerotic; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Transforming Growth Factor beta | 2011 |
Effect of statins on coronary bifurcation atherosclerosis: an intravascular ultrasound virtual histology study.
Topics: Aged; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Disease Progression; Female; Fibrosis; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Logistic Models; Male; Middle Aged; Necrosis; Odds Ratio; Plaque, Atherosclerotic; Predictive Value of Tests; Pyrimidines; Retrospective Studies; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Time Factors; Treatment Outcome; Ultrasonography, Interventional; Vascular Calcification | 2012 |
Plaque-stabilizing statin therapy prior to percutaneous transluminal angioplasty and stenting.
Topics: Acute Coronary Syndrome; Coronary Angiography; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Plaque, Atherosclerotic; Pyrimidines; Sulfonamides; Tomography, X-Ray Computed | 2012 |
The ability of high dose rosuvastatin to improve plaque composition in non-intervened coronary arteries: rationale and design of the Integrated Biomarker and Imaging Study-3 (IBIS-3).
Topics: Biomarkers; Coronary Artery Disease; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Plaque, Atherosclerotic; Prospective Studies; Pyrimidines; Research Design; Rosuvastatin Calcium; Spectroscopy, Near-Infrared; Sulfonamides; Ultrasonography, Interventional | 2012 |